NCT01780688View on ClinicalTrials.gov

Exploratory THS 2.1 Nicotine Pharmacokinetics and Safety Study

NACompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

June 30, 2012

Study Completion Date

December 31, 2012

Conditions
Smoking
Interventions
OTHER

Conventional cigarettes (CC)

Subjects are randomized in a 1:1 fashion to be assigned to one of the 2 sequences, either A) CC and then THS 2.1, or B) THS 2.1 and then CC.

OTHER

THS 2.1

Subjects are randomized in a 1:1 fashion to be assigned in one of the sequences, either A) CC and then THS 2.1, or B) THS 2.1 and then CC

Trial Locations (1)

BT9 AD6

Celerion, 22-24 Lisburn Road, Belfast

All Listed Sponsors
lead

Philip Morris Products S.A.

INDUSTRY

NCT01780688 - Exploratory THS 2.1 Nicotine Pharmacokinetics and Safety Study | Biotech Hunter | Biotech Hunter